The information provided in the report is collected through the EMCDDA’s expert network on drug-related deaths (DRD)
Archives for July 2019
Bibliography: All Publications
Drug related deaths and suicides in prison custody
Analysis of drug-related deaths and suicides in England and Wales, 2008 to 2016 (Office for National Statistics, UK)
Australian NSP Survey National Data Report 2014 – 2018
The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (antibody and RNA) and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia
NIH establishes network to improve opioid addiction treatment in criminal justice settings
Ten clinical research centers will address gaps in accessing high-quality care
Report calls for radical rethink on support given to released prisoners recovering from addiction
A major new report examining the help given to prisoners recovering from addiction has set out a series of “blueprints” which its authors say could “transform” the way prisoners are supported once they have served their sentence (University of York)
Drug-related Deaths in Scotland in 2018
Statistics of drug-related deaths in 2018 and earlier years, broken down by cause of death, selected drugs reported, age and sex (National Records of Scotland)
Trends in Drug-Induced Deaths in Australia, 1997-2017
Each year, the Australian Bureau of Statistics (ABS) makes available to Drug Trends in-depth data on drug-induced deaths in Australia. This year, we have produced a suite of products to summarise trends in drug-induced deaths in Australia from 1997 to 2017 (NDARC)
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017 (HRB, Ireland)
Serbia — Early warning system profile
The profile presents the structure, objectives and working methods of the Serbian national early warning system (EMCDDA)
Drugs policy: medicinal cannabis
Contents section (Parliament, UK)
Stronger evidence needed to improve confidence in medicinal cannabis
Despite the rescheduling of medicinal cannabis, very few prescriptions have been issued. One of the many reasons for this is because of the gaps in the evidence base (Parliament, UK)
New psychoactive substances in Australia: Who uses them, how prevalent are they, and where are they sourced?
In this article, NDARC’s Dr Rachel Sutherland provides an in-depth overview of new psychoactive substances (NPS) in Australia that covers what they are, who uses them and which specific NPS are being consumed (NDARC)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Breaking the embargo: a proposal to break UK public health medicinal cannabis impasse (PDF)
Commissioning national clinical assessments of cannabis-based medicinal products in the management of chronic disease (Centre for Medicinal Cannabis)
